Invitae

Invitae, founded in 2010, is a prominent medical genetics company operating within the Healthcare and Medical Testing & Clinical Laboratories sectors. The company focuses on providing comprehensive genetics testing services. Its operations are supported by a global presence, with Learn about Invitae's global headquarters detailing its primary location. Invitae aims to make genetic information more accessible and actionable for clinicians and patients alike, driving advancements in personalized medicine and improving health management through genetic insights.

With an employee range of 1,000-5,000 individuals, Invitae processes DNA-containing samples from at-home test kits, performing detailed analyses to generate genetic variation reports. Their product portfolio includes various genetic tests, diagnostic panels, and sequencing services designed for applications in oncology, cardiology, and pediatric medicine. The company emphasizes high-quality, state-of-the-art technology to deliver faster turnaround times for critical diagnostic information. For insights into the people driving these innovations, one can explore Meet Invitae's team. Invitae's commitment extends to developing a robust research platform and supporting clinical research initiatives, aiming to integrate genetic testing into routine healthcare.

Invitae has achieved significant revenue, reporting $481.6M. The company has a history of substantial funding, including multiple debt and equity rounds, indicating strong investor confidence in its growth trajectory and market potential. It competes in a dynamic landscape with players like Myriad Genetics, NeoGenomics, and Quest Diagnostics, among others. Invitae's strategic focus on transparent pricing structures and patient-centric services aims to reduce barriers to genetic testing. Further details on its financial performance and market standing are available via Explore financial highlights.